CNBX Pharmaceuticals Inc.

General ticker "CNBX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $137.7K (TTM average)

CNBX Pharmaceuticals Inc. does not follow the US Stock Market performance with the rate: -28.7%.

Estimated limits based on current volatility of 11.8%: low 0.00$, high 0.00$

Factors to consider:

  • Total employees count: 2 (0.0%) as of 2024
  • Top business risk factors: Economic downturns and volatility, Early stage company risks, Labor/talent shortage/retention, Strategic risks and growth management, IT system failures
  • Current price 87.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-08-31 to 2026-08-31

  • 2024-08-31 to 2025-08-31 estimated range: [0.00$, 0.02$]
  • 2025-08-31 to 2026-08-31 estimated range: [0.00$, 0.03$]

Financial Metrics affecting the CNBX estimates:

  • Positive: with PPE of -0.3 at the end of fiscal year the price was very low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -115.17 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: Shareholder equity ratio, % of -7901.54 <= 18.93
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 53.50 > -0.66

Similar symbols

Short-term CNBX quotes

Long-term CNBX plot with estimates

Financial data

YTD 2023-08-31 2024-08-31
Operating Revenue $0.41MM $0.13MM
Operating Expenses $1.34MM $0.71MM
Operating Income $-0.93MM $-0.58MM
Non-Operating Income $-2.78MM $-0.11MM
R&D Expense $0.43MM $0.19MM
Income(Loss) $-3.71MM $-0.70MM
Profit(Loss)* $-3.71MM $-0.69MM
Stockholders Equity $-2.02MM $-2.48MM
Assets $0.50MM $0.03MM
Operating Cash Flow $-0.11MM $-0.24MM
Capital expenditure $0.00MM $0.00MM
Investing Cash Flow $0.02MM $0.11MM
Financing Cash Flow $0.10MM $0.03MM
Earnings Per Share** $-0.42 $-0.02

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.